Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Tetraphase Pharmaceuticals Inc (TTPH) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Tetraphase Pharmaceuticals Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1373707.
Total stock buying since 2014: $8,503,076.
Total stock sales since 2014: $33,853,955.
Total stock option exercises since 2014: $2,950,801.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2020 | 3,972,058 | $8,088,689 | 0 | $0 | 0 | $0 |
| 2019 | 0 | $0 | 30,132 | $62,188 | 0 | $0 |
| 2018 | 0 | $0 | 15,917 | $98,932 | 8,750 | $32,287 |
| 2017 | 14,880 | $107,306 | 33,405 | $199,690 | 66,628 | $205,257 |
| 2016 | 0 | $0 | 0 | $0 | 37,323 | $32,471 |
| 2015 | 0 | $0 | 352,221 | $15,018,926 | 363,134 | $2,560,437 |
| 2014 | 32,825 | $307,081 | 1,088,530 | $18,474,219 | 125,000 | $120,349 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2020-07 | 3,737,360 | $7,474,720 | 0 | $0 | 0 | $0 |
| 2020-06 | 234,698 | $613,969 | 0 | $0 | 0 | $0 |
| 2019-12 | 0 | $0 | 22,635 | $50,193 | 0 | $0 |
| 2019-01 | 0 | $0 | 7,497 | $11,995 | 0 | $0 |
| 2018-01 | 0 | $0 | 15,917 | $98,932 | 8,750 | $32,287 |
| 2017-11 | 3,880 | $25,026 | 0 | $0 | 0 | $0 |
| 2017-10 | 0 | $0 | 8,750 | $52,762 | 8,750 | $32,287 |
| 2017-08 | 0 | $0 | 24,655 | $146,928 | 17,500 | $64,575 |
| 2017-06 | 0 | $0 | 0 | $0 | 10,000 | $20,299 |
| 2017-03 | 11,000 | $82,280 | 0 | $0 | 0 | $0 |
| 2017-02 | 0 | $0 | 0 | $0 | 30,378 | $88,096 |
| 2016-05 | 0 | $0 | 0 | $0 | 25,323 | $22,031 |
| 2016-01 | 0 | $0 | 0 | $0 | 12,000 | $10,440 |
| 2015-10 | 0 | $0 | 0 | $0 | 20,000 | $40,599 |
| 2015-09 | 0 | $0 | 20,000 | $856,500 | 20,000 | $223,900 |
| 2015-08 | 0 | $0 | 84,500 | $3,776,740 | 66,500 | $436,119 |
| 2015-07 | 0 | $0 | 52,500 | $2,575,299 | 37,500 | $281,586 |
| 2015-06 | 0 | $0 | 76,086 | $3,205,173 | 79,999 | $637,283 |
| 2015-05 | 0 | $0 | 65,000 | $2,608,300 | 65,000 | $622,749 |
| 2015-03 | 0 | $0 | 10,000 | $392,849 | 30,000 | $96,800 |
| 2015-02 | 0 | $0 | 10,000 | $355,100 | 10,000 | $79,400 |
| 2015-01 | 0 | $0 | 34,135 | $1,248,965 | 34,135 | $142,001 |
| 2014-10 | 0 | $0 | 247,734 | $5,138,724 | 0 | $0 |
| 2014-09 | 0 | $0 | 572,266 | $9,876,484 | 20,000 | $28,999 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-07-28 | La Jolla Pharmaceutical Co | Buy | 3,737,360 | 2.00 | 7,474,720 |
| 2020-06-19 | La Jolla Pharmaceutical Co | Buy | 234,698 | 2.62 | 613,969 |
| 2019-12-10 | Freund John Gordon (Director) | Sale | 15,031 | 2.19 | 32,917 |
| 2019-12-06 | Macdonald Guy (Director) | Sale | 5,734 | 2.25 | 12,901 |
| 2019-12-05 | Macdonald Guy (Director) | Sale | 1,870 | 2.34 | 4,375 |
| 2019-01-08 | Dumas Jacques (Chief ScientificOfficer) | Sale | 7,497 | 1.60 | 11,995 |
| 2018-01-30 | Dumas Jacques (Chief ScientificOfficer) | Sale | 8,750 | 6.22 | 54,425 |
| 2018-01-30 | Dumas Jacques (Chief ScientificOfficer) | Option Ex | 8,750 | 3.69 | 32,287 |
| 2018-01-09 | Dumas Jacques (Chief ScientificOfficer) | Sale | 7,167 | 6.21 | 44,507 |
| 2017-11-29 | Gage L Patrick (Director) | Buy | 3,880 | 6.45 | 25,026 |
| 2017-10-31 | Dumas Jacques (Chief ScientificOfficer) | Sale | 8,750 | 6.03 | 52,762 |
| 2017-10-31 | Dumas Jacques (Chief ScientificOfficer) | Option Ex | 8,750 | 3.69 | 32,287 |
| 2017-08-22 | Dumas Jacques (Chief ScientificOfficer) | Sale | 17,500 | 6.00 | 105,000 |
| 2017-08-22 | Dumas Jacques (Chief ScientificOfficer) | Option Ex | 17,500 | 3.69 | 64,575 |
| 2017-08-17 | Dumas Jacques (Chief ScientificOfficer) | Sale | 7,155 | 5.86 | 41,928 |
| 2017-06-13 | Horn Patrick Taylor (Chief Medical Officer) | Option Ex | 10,000 | 2.03 | 20,299 |
| 2017-03-15 | Gage L Patrick (Director) | Buy | 11,000 | 7.48 | 82,280 |
| 2017-02-09 | Macdonald Guy (President and Chief Executive) | Option Ex | 30,378 | 2.90 | 88,096 |
| 2016-05-16 | Macdonald Guy (President and Chief Executive) | Option Ex | 25,323 | .87 | 22,031 |
| 2016-01-06 | Macdonald Guy (President and Chief Executive) | Option Ex | 12,000 | .87 | 10,440 |
| 2015-10-02 | Gage L Patrick (Director) | Option Ex | 20,000 | 2.03 | 40,599 |
| 2015-09-08 | Thompson John Craig (Chief Operating Officer) | Sale | 10,000 | 44.08 | 440,800 |
| 2015-09-08 | Thompson John Craig (Chief Operating Officer) | Option Ex | 10,000 | 14.45 | 144,500 |
| 2015-09-01 | Macdonald Guy (President and Chief Executive) | Sale | 10,000 | 41.57 | 415,700 |
| 2015-09-01 | Macdonald Guy (President and Chief Executive) | Option Ex | 10,000 | 7.94 | 79,400 |
| 2015-08-24 | Macdonald Guy (President and Chief Executive) | Option Ex | 12,000 | .87 | 10,440 |
| 2015-08-14 | Lubner David Charles (SVP and CFO) | Sale | 9,500 | 42.92 | 407,740 |
| 2015-08-14 | Lubner David Charles (SVP and CFO) | Option Ex | 9,500 | 7.94 | 75,430 |
| 2015-08-13 | Horn Patrick Taylor (Chief Medical Officer) | Sale | 10,000 | 44.69 | 446,900 |
| 2015-08-13 | Horn Patrick Taylor (Chief Medical Officer) | Option Ex | 10,000 | 2.03 | 20,299 |
| 2015-08-12 | Gage L Patrick (Director) | Sale | 15,000 | 45.00 | 675,000 |
| 2015-08-12 | Gage L Patrick (Director) | Option Ex | 15,000 | 7.07 | 106,050 |
| 2015-08-06 | Macdonald Guy (President and Chief Executive) | Sale | 30,000 | 43.65 | 1,309,500 |
| 2015-08-05 | Thompson John Craig (Chief Operating Officer) | Sale | 10,000 | 46.31 | 463,100 |
| 2015-08-05 | Thompson John Craig (Chief Operating Officer) | Option Ex | 10,000 | 14.45 | 144,500 |
| 2015-08-03 | Macdonald Guy (President and Chief Executive) | Sale | 10,000 | 47.45 | 474,500 |
| 2015-08-03 | Macdonald Guy (President and Chief Executive) | Option Ex | 10,000 | 7.94 | 79,400 |
| 2015-07-20 | Macdonald Guy (President and Chief Executive) | Sale | 15,000 | 50.72 | 760,800 |
| 2015-07-14 | Lubner David Charles (SVP and CFO) | Sale | 7,500 | 48.92 | 366,900 |
| 2015-07-14 | Lubner David Charles (SVP and CFO) | Option Ex | 7,500 | 4.99 | 37,387 |
| 2015-07-13 | Horn Patrick Taylor (Chief Medical Officer) | Sale | 10,000 | 48.93 | 489,300 |
| 2015-07-13 | Horn Patrick Taylor (Chief Medical Officer) | Option Ex | 10,000 | 2.03 | 20,299 |
| 2015-07-06 | Thompson John Craig (Chief Operating Officer) | Sale | 10,000 | 47.91 | 479,099 |
| 2015-07-06 | Thompson John Craig (Chief Operating Officer) | Option Ex | 10,000 | 14.45 | 144,500 |
| 2015-07-01 | Macdonald Guy (President and Chief Executive) | Sale | 10,000 | 47.92 | 479,200 |
| 2015-07-01 | Macdonald Guy (President and Chief Executive) | Option Ex | 10,000 | 7.94 | 79,400 |
| 2015-06-15 | Lubner David Charles (SVP and CFO) | Sale | 7,500 | 41.67 | 312,525 |
| 2015-06-15 | Lubner David Charles (SVP and CFO) | Option Ex | 7,500 | 2.03 | 15,224 |
| 2015-06-15 | Thompson John Craig (Chief Operating Officer) | Sale | 10,000 | 41.51 | 415,100 |
| 2015-06-15 | Thompson John Craig (Chief Operating Officer) | Option Ex | 10,000 | 14.45 | 144,500 |
| 2015-06-12 | Horn Patrick Taylor (Chief Medical Officer) | Sale | 10,000 | 41.72 | 417,200 |
| 2015-06-12 | Horn Patrick Taylor (Chief Medical Officer) | Option Ex | 10,000 | 2.03 | 20,299 |
| 2015-06-12 | Lubner David Charles (SVP and CFO) | Sale | 10,000 | 41.29 | 412,900 |
| 2015-06-08 | Thompson John Craig (Chief Operating Officer) | Sale | 22,499 | 43.25 | 973,081 |
| 2015-06-08 | Thompson John Craig (Chief Operating Officer) | Option Ex | 22,499 | 14.45 | 325,110 |
| 2015-06-01 | Macdonald Guy (President and Chief Executive) | Sale | 16,087 | 41.92 | 674,367 |
| 2015-06-01 | Macdonald Guy (President and Chief Executive) | Option Ex | 30,000 | 4.41 | 132,150 |
| 2015-05-15 | Thompson John Craig (Chief Operating Officer) | Sale | 30,000 | 39.63 | 1,188,900 |
| 2015-05-15 | Thompson John Craig (Chief Operating Officer) | Option Ex | 30,000 | 14.45 | 433,500 |
| 2015-05-14 | Lubner David Charles (SVP and CFO) | Sale | 15,000 | 39.28 | 589,200 |
| 2015-05-14 | Lubner David Charles (SVP and CFO) | Option Ex | 15,000 | 2.03 | 30,449 |
| 2015-05-11 | Macdonald Guy (President and Chief Executive) | Sale | 20,000 | 41.51 | 830,200 |
| 2015-05-11 | Macdonald Guy (President and Chief Executive) | Option Ex | 20,000 | 7.94 | 158,800 |
| 2015-03-26 | Macdonald Guy (President and Chief Executive) | Option Ex | 20,000 | .87 | 17,400 |
| 2015-03-02 | Macdonald Guy (President and Chief Executive) | Sale | 10,000 | 39.28 | 392,849 |
| 2015-03-02 | Macdonald Guy (President and Chief Executive) | Option Ex | 10,000 | 7.94 | 79,400 |
| 2015-02-02 | Macdonald Guy (President and Chief Executive) | Sale | 10,000 | 35.51 | 355,100 |
| 2015-02-02 | Macdonald Guy (President and Chief Executive) | Option Ex | 10,000 | 7.94 | 79,400 |
| 2015-01-20 | Macdonald Guy (President and Chief Executive) | Sale | 34,135 | 36.59 | 1,248,965 |
| 2015-01-20 | Macdonald Guy (President and Chief Executive) | Option Ex | 34,135 | 4.16 | 142,001 |
| 2014-10-02 | Freund John Gordon (Director) | Sale | 105,588 | 20.87 | 2,203,410 |
| 2014-10-01 | Freund John Gordon (Director) | Sale | 142,146 | 20.65 | 2,935,314 |
| 2014-09-30 | Freund John Gordon (Director) | Sale | 56,618 | 20.17 | 1,141,871 |
| 2014-09-29 | Freund John Gordon (Director) | Sale | 95,648 | 20.19 | 1,931,324 |
| 2014-09-23 | Macdonald Guy (President and Chief Executive) | Sale | 10,000 | 18.47 | 184,660 |
| 2014-09-23 | Macdonald Guy (President and Chief Executive) | Option Ex | 10,000 | 2.03 | 20,299 |
| 2014-09-17 | Macdonald Guy (President and Chief Executive) | Sale | 10,000 | 18.00 | 180,000 |
| 2014-09-17 | Macdonald Guy (President and Chief Executive) | Option Ex | 10,000 | .87 | 8,700 |
| 2014-09-17 | Freund John Gordon (Director) | Sale | 77,000 | 17.36 | 1,336,566 |
| 2014-09-16 | Freund John Gordon (Director) | Sale | 67,356 | 17.03 | 1,147,140 |
| 2014-09-12 | Freund John Gordon (Director) | Sale | 53,544 | 17.01 | 910,783 |
| 2014-09-11 | Freund John Gordon (Director) | Sale | 2,100 | 17.00 | 35,708 |
| 2014-09-08 | Freund John Gordon (Director) | Sale | 4,473 | 15.01 | 67,126 |
| 2014-09-05 | Freund John Gordon (Director) | Sale | 12,227 | 15.01 | 183,527 |
| 2014-09-04 | Freund John Gordon (Director) | Sale | 41,200 | 15.06 | 620,595 |
| 2014-09-03 | Freund John Gordon (Director) | Sale | 142,100 | 15.04 | 2,137,184 |
| 2014-08-20 | Macdonald Guy (President and Chief Executive) | Sale | 10,000 | 11.59 | 115,900 |
| 2014-08-20 | Macdonald Guy (President and Chief Executive) | Option Ex | 10,000 | .87 | 8,700 |
| 2014-08-05 | Macdonald Guy (President and Chief Executive) | Option Ex | 25,000 | .87 | 21,750 |
| 2014-07-18 | Macdonald Guy (President and Chief Executive) | Sale | 15,000 | 10.61 | 159,105 |
| 2014-07-18 | Macdonald Guy (President and Chief Executive) | Option Ex | 40,000 | .87 | 34,800 |
| 2014-06-23 | Freund John Gordon (Director) | Sale | 47,184 | 13.77 | 649,912 |
| 2014-06-20 | Freund John Gordon (Director) | Sale | 82,716 | 13.65 | 1,128,907 |
| 2014-06-19 | Freund John Gordon (Director) | Sale | 70,100 | 13.08 | 916,697 |
| 2014-06-17 | Lubner David Charles (SVP and CFO) | Sale | 13,530 | 12.51 | 169,260 |
| 2014-06-17 | Macdonald Guy (President and Chief Executive) | Sale | 15,000 | 12.28 | 184,230 |
| 2014-06-17 | Macdonald Guy (President and Chief Executive) | Option Ex | 15,000 | .87 | 13,050 |
| 2014-06-13 | Gage L Patrick (Director) | Buy | 500 | 11.42 | 5,710 |
| 2014-06-05 | Gage L Patrick (Director) | Buy | 975 | 10.28 | 10,026 |
| 2014-06-04 | Gage L Patrick (Director) | Buy | 500 | 10.05 | 5,025 |
| 2014-05-28 | Gage L Patrick (Director) | Buy | 850 | 10.70 | 9,095 |
| 2014-05-19 | Gullans Steven R. Ph.d. (Director) | Buy | 25,000 | 9.24 | 230,975 |
| 2014-05-19 | Macdonald Guy (President and Chief Executive) | Sale | 15,000 | 9.00 | 135,000 |
| 2014-05-19 | Macdonald Guy (President and Chief Executive) | Option Ex | 15,000 | .87 | 13,050 |
| 2014-05-14 | Gage L Patrick (Director) | Buy | 5,000 | 9.25 | 46,250 |
Insider trading activities including stock purchases, stock sales, and option exercises of TTPH listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Tetraphase Pharmaceuticals Inc (symbol TTPH, CIK number 1373707) see the Securities and Exchange Commission (SEC) website.